Literature DB >> 5118204

Treatment of Kaposi's sarcoma with actinomycin-D and cyclophosphamide: results of a randomized clinical trial.

C L Vogel, C J Templeton, A C Templeton, J F Taylor, S K Kyalwazi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5118204     DOI： 10.1002/ijc.2910080117

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  5 in total

Review 1.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Kaposi's sarcoma in an Eskimo.

Authors:  S R Masse; G A Glazebrook
Journal:  Can Med Assoc J       Date:  1974-10-19       Impact factor: 8.262

3.  Growth kinetics of Kaposi's sacroma.

Authors:  J F Taylor; O H Iversen; R Bjerknes
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640

4.  Childhood Kaposi's sarcoma: clinical features and therapy.

Authors:  C L Olweny; A Kaddumukasa; I Atine; R Owor; I Magrath; J L Ziegler
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

5.  Delayed cutaneous hypersensitivity reactions in patients with Kaposi's sarcoma.

Authors:  J F Taylor; J L Ziegler
Journal:  Br J Cancer       Date:  1974-10       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.